PCR Press Releases

NEW YORK – PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020 - #PCReCourse) and CRF’s TVT Connect meeting (June 18-28, 2020). The sessions, which will cover coronary artery...

Paris, France, 5 May 2020. It has been announced that EuroPCR 2020 is cancelled. The 31st edition of the annual World-Leading Course in interventional cardiovascular medicine was due to take place in Paris, France on 19-22 May. The sanitary and legal environment, and in particular the...

New York, NY – Tuesday 21, 2020 – PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning”. The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It...

Paris, France, 24 May 2019. A total of 11,206 participants from over 120 different countries were present at the 30th edition of EuroPCR. An additional 4,700 online learners connected to watch a selection of sessions that were made available both live and on replay via PCR...

Paris, France, 22 May 2019. Identification and management of patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI) is of major importance, but a lack of standardisation in defining this population limits trial design, data interpretation, and clinical decision-making.

Paris, France, 21 May 2019. This PCR statement on paclitaxel drug-coated balloons (DCB) use in peripheral interventions addresses the controversy raised by the meta-analysis of K. Katsanos, MD, PhD (Patras University Hospital, Rion, Greece) and colleagues, published in late 2018 (https://doi.org/10.1161/JAHA.118.011245). The Katsanos meta-analysis prompted widespread...

Paris, France, 21 May 2019. Intra-coronary (IC) imaging has been available for over two decades. Technological advances, with the development of new modalities and improvements in the software to facilitate “real-time” analysis and decision making, have seen an increased use for both diagnostic assessment and the...

Paris, France, 21 May 2019. Severe symptomatic aortic stenosis, a degenerative disease-causing calcification and immobility of the aortic valve leaflets leading to left ventricular outflow obstruction, is the most common valve lesion leading to intervention in Europe and the USA. Symptoms include heart failure, syncope and...

Paris, France, 21 May 2019. Heart failure is a common cardiovascular disorder with ominous prognosis despite significant therapeutic advances. Mitral regurgitation (MR, leaking of the mitral valve within the heart) affects at least 50% of patients with heart failure and is independently associated with worse prognosis....

EuroPCR is the place to be to hear the latest news about cardiovascular interventions. This year also marks the 30th anniversary of the Course. EuroPCR is expecting 10,000+ participants for its patient-oriented 4-day Course built “by and for” the community. Interventional cardiologists, surgeons, imaging specialists, nurses,...